The combined observation of information about cerebral glucose metabolism (N-status) and APOE-genotype (genetic predisposition for AD), as well as demographic factors, such as age and sex, enhance prognostic accuracy of AD in patients with MCI [16]. Here, APOE is linked to Alzheimer disease.